Zofran Birth Defect Defendant Files FDA Citizen Petition As Part Of Preemption Bid

Mealey's (November 20, 2019, 1:48 PM EST) -- BOSTON — GlaxoSmithKline LLC (GSK) on Nov. 1 filed a citizen petition asking the Food and Drug Administration for an opinion about Zofran’s birth defect warnings, a move that plaintiffs in...
To view the full article, register now.